Vaccinex (VCNX) Financials

$1.05

$0.45 (75.00%)

As on 09-Sep-2026 10:19EDT

Market cap

$2 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

7.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	2.10	0.60	0.57	0.10	0.90	0.05
Cost of Revenue	0.04	--	0.12	0.21	0.17	0.00
Gross Profit	2.06	0.60	0.57	0.07	0.73	0.05
Operating Expenses	7.29	19.34	23.46	20.01	23.22	28.38
Operating Profit (EBIT)	-5.23	-18.74	-22.89	-19.91	-22.49	-28.33
Other Income	--	--	--	--	--	--
Profit before Tax	-5.26	-18.63	-20.25	-19.82	-22.38	-28.85
Provision for Tax	--	-18.63	-0.05	-0.09	0.85	0.46
Profit after Tax (Net Income)	-5.26	-18.63	-20.25	-19.72	-22.38	-28.85
Minority Interest	--	--	--	--	--	23.96
Consolidated Profit	--	--	--	--	-22.38	-28.85

Liabilities ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	-7.59	-2.49	-2.31	5.19	7.41	-26.58
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	5.52	--	0.03	0.25	0.18	1.13
Current Liabilities	3.87	5.08	5.92	2.54	2.26	13.18
Total Liabilities	1.80	2.60	3.63	7.98	9.84	11.70

Assets ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	0.04	0.07	0.28	0.50	0.44	0.42
Current Assets	1.76	2.53	3.35	7.48	9.41	11.29
Total Assets	1.80	2.60	3.63	7.98	9.84	11.70
Total Debt*	5.52	0.03	0.25	0.49	0.39	9.21
Net Current Assets	--	-2.55	-2.57	4.94	7.15	-1.89

Cashflow ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	-6.45	-16.19	-17.23	-19.07	-25.30	-28.65
Cash Flow from Investing Activities	-0.01	-0.02	-0.07	-0.10	-0.03	-0.29
Cash from Financing Activities	5.49	15.78	12.45	16.98	23.32	36.76
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-2.51	-6.96	-22.69	-97.34	-152.56	-270.65
Cash EPS ($)	-2.51	-6.93	-22.53	-96.32	-151.40	-267.77
Adjusted Book Value ($)	--	--	--	25.63	50.52	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-3.07	-6.05	-19.31	-94.15	-172.45	-268.73
Free Cash Flow per Share ($)	-3.08	-6.06	-19.38	-94.63	-172.67	-271.45

Profitability Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	231.87	823.24	-1,120.70	-292.61	467.96	132.33
ROE (%)	104.38	776.58	-1,405.34	-312.92	233.58	109.26
ROA (%)	-239.36	-598.49	-348.91	-221.35	-207.75	-353.87
EBIT Margin (%)	-249.74	-3,100.17	-3,485.44	-19,813.00	-2,396.78	-56,724.00
Net Margin (%)	-251.07	-3,100.50	-3,552.81	-19,722.00	-2,486.67	-57,702.00
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	2.49	0.05	4.70	-0.89	17.00	-0.90
EBIT Growth (%)	71.92	6.22	-0.27	8.15	23.94	10.99
Net Profit Growth (%)	71.77	7.98	-2.68	11.88	22.43	9.88
EPS Growth (%)	0.64	0.69	0.77	0.36	0.44	0.40
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	-0.14	-0.03	-0.01	-0.01	-0.01
Price / Book Value	--	-1.05	-0.25	0.03	0.02	-0.01
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	--	-0.08	0.04	0.29	0.38	0.04
Close Price ($)	--	0.98	9.24	135.35	218.40	434.70
High Price ($)	--	13.02	173.04	478.80	2,007.60	2,568.30
Low Price ($)	--	0.71	7.42	86.10	218.40	342.30
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	-0.73	-0.01	-0.11	0.09	0.05	-0.35
Short term debt to equity ratio	--	-0.01	-0.10	0.05	0.03	-0.30
Current Ratio	0.45	0.50	0.57	2.95	4.17	0.86
Quick Ratio	--	--	--	2.95	--	0.86
Interest Coverage	-39.64	-9,316.00	-19,867.00	-9,906.50	-26.66	-58.00

Operating Efficiency Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	55.13	139.43	168.60	175.00	--	314.00
Asset Turnover	0.95	0.19	0.10	0.01	0.08	0.01
Receivable days	173.73	546.66	363.97	319.59	31.86	3,853.39
Inventory Days	--	--	0.00	0.00	0.00	0.18
Payable days	38,732.15	--	5,458.80	2,275.31	4,571.03	582,299.81
Cash Conversion Cycle	--	--	-5,094.83	-1,955.72	-4,539.17	-578,446.24